Literature DB >> 23994472

The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons.

Yoshiho Ikeuchi1, Luis de la Torre-Ubieta, Takahiko Matsuda, Hanno Steen, Hitoshi Okazawa, Azad Bonni.   

Abstract

Intellectual disability (ID) is a prevalent developmental disorder of cognition that remains incurable. Here, we report that knockdown of the X-linked ID (XLID) protein polyglutamine-binding protein 1 (PQBP1) in neurons profoundly impairs the morphogenesis of the primary cilium, including in the mouse cerebral cortex in vivo. PQBP1 is localized at the base of the neuronal cilium, and targeting its WW effector domain to the cilium stimulates ciliary morphogenesis. We also find that PQBP1 interacts with Dynamin 2 and thereby inhibits its GTPase activity. Accordingly, Dynamin 2 knockdown in neurons stimulates ciliogenesis and suppresses the PQBP1 knockdown-induced ciliary phenotype. Strikingly, a mutation of the PQBP1 WW domain that causes XLID disrupts its ability to interact with and inhibit Dynamin 2 and to induce neuronal ciliogenesis. These findings define PQBP1 and Dynamin 2 as components of a signaling pathway that orchestrates neuronal ciliary morphogenesis in the brain.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23994472      PMCID: PMC4013279          DOI: 10.1016/j.celrep.2013.07.042

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  61 in total

1.  Prevalence of mental retardation and developmental disabilities: estimates from the 1994/1995 National Health Interview Survey Disability Supplements.

Authors:  S A Larson; K C Lakin; L Anderson; N Kwak; J H Lee; D Anderson
Journal:  Am J Ment Retard       Date:  2001-05

Review 2.  Cell biology of the presynaptic terminal.

Authors:  Venkatesh N Murthy; Pietro De Camilli
Journal:  Annu Rev Neurosci       Date:  2003       Impact factor: 12.449

3.  Cdh1-APC controls axonal growth and patterning in the mammalian brain.

Authors:  Yoshiyuki Konishi; Judith Stegmüller; Takahiko Matsuda; Shirin Bonni; Azad Bonni
Journal:  Science       Date:  2004-01-08       Impact factor: 47.728

4.  Dendritic spine "dysgenesis" and mental retardation.

Authors:  D P Purpura
Journal:  Science       Date:  1974-12-20       Impact factor: 47.728

5.  Evidence that dim1 associates with proteins involved in pre-mRNA splicing, and delineation of residues essential for dim1 interactions with hnRNP F and Npw38/PQBP-1.

Authors:  Y Zhang; T Lindblom; A Chang; M Sudol; A E Sluder; E A Golemis
Journal:  Gene       Date:  2000-10-17       Impact factor: 3.688

Review 6.  Dendritic anomalies in disorders associated with mental retardation.

Authors:  W E Kaufmann; H W Moser
Journal:  Cereb Cortex       Date:  2000-10       Impact factor: 5.357

7.  Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly.

Authors:  Kirk Mykytyn; Robert F Mullins; Michael Andrews; Annie P Chiang; Ruth E Swiderski; Baoli Yang; Terry Braun; Thomas Casavant; Edwin M Stone; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

8.  PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype.

Authors:  Tomohiro Okuda; Hiroshi Hattori; Sousuke Takeuchi; Jun Shimizu; Hiroko Ueda; Jorma J Palvimo; Ichiro Kanazawa; Hitoshi Kawano; Masaya Nakagawa; Hitoshi Okazawa
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

9.  Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion.

Authors:  Heather M Thompson; Hong Cao; Jing Chen; Ursula Euteneuer; Mark A McNiven
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

10.  Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death.

Authors:  Hitoshi Okazawa; Tina Rich; Alex Chang; Xi Lin; Masaaki Waragai; Masunori Kajikawa; Yasushi Enokido; Akihiko Komuro; Seishi Kato; Masao Shibata; Hiroshi Hatanaka; M Maral Mouradian; Marius Sudol; Ichiro Kanazawa
Journal:  Neuron       Date:  2002-05-30       Impact factor: 17.173

View more
  5 in total

1.  PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1.

Authors:  Janna Seifried; Stephen Soonthornvacharin; Sunnie M Yoh; Monika Schneider; Rana E Akleh; Kevin C Olivieri; Paul D De Jesus; Chunhai Ruan; Elisa de Castro; Pedro A Ruiz; David Germanaud; Vincent des Portes; Adolfo García-Sastre; Renate König; Sumit K Chanda
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

Review 2.  Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

Authors:  Hitoshi Okazawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

3.  Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation.

Authors:  Meihua Jin; Hiroki Shiwaku; Hikari Tanaka; Takayuki Obita; Sakurako Ohuchi; Yuki Yoshioka; Xiaocen Jin; Kanoh Kondo; Kyota Fujita; Hidenori Homma; Kazuyuki Nakajima; Mineyuki Mizuguchi; Hitoshi Okazawa
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

4.  In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells.

Authors:  H Ito; H Shiwaku; C Yoshida; H Homma; H Luo; X Chen; K Fujita; L Musante; U Fischer; S G M Frints; C Romano; Y Ikeuchi; T Shimamura; S Imoto; S Miyano; S-i Muramatsu; T Kawauchi; M Hoshino; M Sudol; A Arumughan; E E Wanker; T Rich; C Schwartz; F Matsuzaki; A Bonni; V M Kalscheuer; H Okazawa
Journal:  Mol Psychiatry       Date:  2014-07-29       Impact factor: 15.992

5.  The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.

Authors:  Hikari Tanaka; Kanoh Kondo; Xigui Chen; Hidenori Homma; Kazuhiko Tagawa; Aurelian Kerever; Shigeki Aoki; Takashi Saito; Takaomi Saido; Shin-Ichi Muramatsu; Kyota Fujita; Hitoshi Okazawa
Journal:  Mol Psychiatry       Date:  2018-10-03       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.